Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors.
about
New perspectives in glioblastoma antiangiogenic therapyBevacizumab for glioblastomaMolecularly targeted drugs for metastatic colorectal cancerDexamethasone alleviates tumor-associated brain damage and angiogenesisLow-dose bevacizumab induces radiographic regression of vestibular schwannomas in neurofibromatosis type 2: A case report and literature reviewNanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts.Increased risk of cerebrovascular events in patients with cancer treated with bevacizumab: a meta-analysis.Efficacy of temozolomide and bevacizumab for the treatment of leptomeningeal dissemination of recurrent glioblastoma: A case report.A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activityEffective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis.Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors.The molecular mechanisms underlying the therapeutic resistance of cancer stem cells.Predictors of Venous Thromboembolism in Patients with Glioblastoma.Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis.Leakage decrease detected by dynamic susceptibility-weighted contrast-enhanced perfusion MRI predicts survival in recurrent glioblastoma treated with bevacizumab.Bevacizumab is superior to Temozolomide in causing mitochondrial dysfunction in human brain tumors.Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications.Carboxyethylpyrroles: From Hypothesis to the Discovery of Biologically Active Natural Products.Effect of Endostar combined with angiopoietin-2 inhibitor on malignant pleural effusion in mice.Anti-Vascular Endothelial Growth Factor Treatment Suppresses Early Brain Injury After Subarachnoid Hemorrhage in Mice.Adjuvant Radiation Therapy and Temozolomide in Gliosarcoma: Is It Enough? Case Series of Seven Patients.Trends in Malignant Glioma Monoclonal Antibody Therapy.
P2860
Q26746028-5A817FBF-4148-447C-B905-C4A4EF189F6EQ26776307-3701A3D2-3A75-4D00-A749-2CA93E756ADDQ26828735-2796C455-5CA4-4DC3-A5F8-D97282EBDE01Q28542092-34F594E2-6CEF-4995-9253-0086D6CD0A21Q30385105-855B1797-9104-424F-B82D-54F8F7C17420Q33627880-64399B82-5786-480B-AD3C-BB276085D72FQ33904867-A544672F-E1E7-430C-9CD2-44519506D315Q35167719-A34675FF-1CCB-4E8A-9597-E9C2C49EF5D9Q35604265-AAB1D321-63E0-4596-ABB5-EA985EB1804EQ35788820-EFED9120-09AC-4DB6-ADDC-777D05E3C0DDQ36037733-3538DE74-B1BB-457A-A9C1-39595D07F7B5Q38287226-32CF6EFD-900B-471A-A952-CB2BA69B27C6Q38627862-24426217-EDE2-4732-8A55-6685376C022AQ38972501-82422CF1-564C-4B6A-B9F1-A1C7E9F43381Q40827837-E9A76C4A-3C80-4535-9423-C4520CEC2D03Q46563593-DA0688AE-4BEC-418E-8D97-58CB94F03792Q47942947-B4A32F24-6F8E-4B03-9979-1F36FD2DB784Q50312729-1331B0B5-5890-4043-89F9-DAB6A66A82FBQ51027515-A8B5A930-FD80-46CA-83E5-84684FF2054CQ52151011-AD27DA2F-B61D-4898-9A29-2990094CC4ECQ52571331-E651C6F1-8DB9-4834-8D62-731EDD4C01AEQ54942652-F6E549CC-9C39-4DE5-B30E-6F606CF89BA8
P2860
Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors.
@ast
Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors.
@en
type
label
Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors.
@ast
Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors.
@en
prefLabel
Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors.
@ast
Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors.
@en
P2860
P356
P1476
Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors.
@en
P2093
Yoshitaka Narita
P2860
P304
P356
10.1093/JJCO/HYT051
P577
2013-04-12T00:00:00Z